1/2 Cross modal integration of molecular and physiological networks in ASD
1/2 Cross modal integration of molecular and physiological networks in ASD
批准号:
10224680
负责人:
DANIEL H GESCHWIND
金额:
$99.31万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-21 至 2023-07-31
关键词:
3-DimensionalAddressAnimal ModelAreaArray tomographyAstrocytesAutopsyBehaviorBiologicalBiological AssayBiological ModelsBiophysicsBrainBrain DiseasesCRISPR/Cas technologyCalciumCellsChromatinCognitive deficitsCollaborationsComplexComputer ModelsDataDevelopmentDisease modelElectric StimulationElectrodesEngineeringEquilibriumFaceFunctional disorderGene ExpressionGene ProteinsGenesGeneticGenetic EngineeringGenetic HeterogeneityGenetic ModelsGenetic RiskGenetic TranscriptionGenetic VariationGenomicsGlutamatesHumanHuman GeneticsImageImpairmentIn VitroIndividualInterneuronsInvestigationLeadLinkMeasuresMental disordersMessenger RNAMethodologyModalityModelingMolecularMorphologyMutationNervous System PhysiologyNeurobiologyNeurogliaNeuronal PlasticityNeuronsOpticsOrganoidsPathway interactionsPatientsPatternPhagocytosisPhenotypePhysicsPhysiologicalPhysiologyPrincipal InvestigatorPropertyProsencephalonRadialRattusResearch PersonnelRiskRodentRodent ModelRoleStructureSynapsesSynaptosomesSyndromeSystemTestingTissuesUntranslated RNAWorkautism spectrum disorderbasebiophysical modelcell typedensitydisorder riskexperimental studyfetalflexibilityfunctional genomicsgenetic approachgenetic architecturegenetic associationgenetic risk factorgenetic varianthigh riskhuman diseasehuman modelhuman stem cellsimmunocytochemistryin vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinnovationmigrationmolecular pathologynetwork modelsneurogenesisneuropsychiatric disordernovelnovel strategiesoptogeneticspatch clamppredictive modelingpredictive testprogenitorrelating to nervous systemrisk variantsequence learningsingle cell analysissingle-cell RNA sequencingstem cell modelstem cellssynaptogenesistheoriesthree dimensional cell culturevirtual reality
中文摘要
遗传学方法已经成功地识别了常见和罕见的原因遗传因素
增加自闭症谱系障碍(ASD)的风险,为机械性疾病提供了一个重要的起点
神经生物学研究。然而,要对ASD有一个完整的机制理解,请访问
分子、细胞和电路层面面临着巨大的挑战,例如极端的遗传异质性。
以及缺乏用于连接不同层次的神经系统分析的因果框架
在模型系统或患者中发挥作用。近十年前,我们认为基因和蛋白质网络
将提供一个组织框架,以了解不同类型的精神疾病遗传风险
统一的背景和信息疾病建模;确实,现在有大量证据支持
胎儿中期皮质发育过程中主要效应风险基因的趋同。此外,相关泛函
基因组研究,包括那些具有ASD(DUP)15q11-13主要基因形式的人,显示出共同的模式
死后ASD脑内转录和染色质失调,进一步支持生物学
融合。这种情况在哪里发生,如何发生,以及它反映了什么生物学机制(S),目前尚不清楚。至
为了解决这个问题,我们提出了一个雄心勃勃的项目,解决了在确定因果关系方面的几个主要挑战
ASD的遗传风险与中枢神经系统结构和功能之间的联系。在这个多PI-U01中提出的工作
涉及一个由来自加州大学洛杉矶分校和斯坦福大学的四名首席调查人员和联合调查人员组成的团队,他们具有
有必要使用最先进的方法来执行这项工作,包括开发和
描述人类大脑发育、干细胞、生理学、基因组学、物理学和
行为。通过密切合作,我们将开发和分析基于体外人类干细胞的模型
从诱导的多能干细胞分化并组装成有组织的3D脑培养
被称为人类前脑球体(HFS)。这些HF包含正在开发的
前脑,包括前体细胞、放射状胶质细胞、皮质中间神经元、谷氨酸能神经元和非反应性神经元
星形胶质细胞,形成功能性突触。我们将模拟六个主要影响ASD风险基因座对HFS的影响
使用分子、基因组和生理分析来评估每个分析级别的融合。我们会
利用体外模拟的相同基因,对三种啮齿动物模型进行了生理学比较
目的是整合表型以开发预测模型并与体内啮齿动物模型进行比较。
我们将分析分子变化和基本细胞和突触特征与潜能的关系
控制派生的HFS中的紧急或动态网络特征,并将这些特征与HFS
ASD风险突变,并基于网络模型预测测试因果关系的子集。完成
这些目标将使我们更清楚地理解模型系统的力量和局限性
计算模型,同时揭示了ASD不同遗传形式的潜在收敛区域。
英文摘要
Genetic approaches have been successful in identifying causal genetic factors, both common and rare, that
contribute to risk for autism spectrum disorder (ASD), providing a crucial starting point for mechanistic
neurobiological investigations. However, moving towards an integrated mechanistic understanding of ASD at
a molecular, cellular, and circuit level faces substantial challenges, such as extreme genetic heterogeneity
and the lack of causal frameworks with which to connect different levels of analysis of nervous system
function in model systems or patients. Nearly a decade ago, we reasoned that gene and protein networks
would provide an organizing framework for understanding heterogeneous psychiatric disease genetic risk in a
unified context and inform disease modeling; indeed there is now substantial evidence supporting
convergence of major effect risk genes during mid-fetal cortical development. Furthermore, related functional
genomic studies, including in those with a major gene form of ASD (dup)15q11-13, show shared patterns of
transcriptional and chromatin dysregulation in post-mortem ASD brain, further supporting biological
convergence. Where and how this occurs, and what biological mechanism(s) it reflects is not known. To
address this, we propose an ambitious project that addresses several major challenges in establishing causal
linkages between genetic risk and CNS structure and function in ASD. The work proposed in this multi-PI U01
involves a team of four principal investigators and co-investigators from UCLA and Stanford with the expertise
necessary to perform this work using state of the art methodologies, ranging from developing and
characterizing in vitro models of human brain development, stem cells, physiology, genomics, physics, and
behavior. Through close collaboration, we will develop and analyze in vitro human stem cell based models
that are differentiated from induced pluripotent stem cells and assembled into organized 3D brain cultures
called human forebrain spheroids (hFS). These hFS contain the major cell classes of the developing
forebrain, including progenitors, radial glia, cortical interneurons, glutamatergic neurons, and non-reactive
astrocytes, and form functional synapses. We will model the effects of six major effect ASD risk loci in hFS
with molecular, genomic, and physiological analyses to assess convergence at each level of analysis. We will
also conduct comparisons of physiology using three rodent models based on the same genes modeled in vitro
with the aim of integrating phenotypes to develop predictive models and compare with in vivo rodent models.
We will analyze the relationship of molecular alterations and basic cellular and synaptic features with potential
emergent or dynamic network features in control-derived hFS and compare these features with hFS harboring
ASD risk mutations and test a subset of causal relationships based on network model predictions. Completion
of these aims will lead to a more clear understanding of the power and limitations of model systems and
computational models, while uncovering potential areas of convergence in different genetic forms of ASD.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41380-019-0576-0
发表时间:
2021-05-01
期刊:
Molecular psychiatry
影响因子:
11
作者:
[Gordon, Aaron, Forsingdal, Annika, Geschwind, Daniel H]
通讯作者:
Geschwind, Daniel H
DOI:
10.1016/j.celrep.2019.05.006
发表时间:
2019-05-28
期刊:
CELL REPORTS
影响因子:
8.8
作者:
[Lazaro, Maria T., Taxidis, Jiannis, Golshani, Peyman]
通讯作者:
Golshani, Peyman
DOI:
10.1186/s13059-020-02257-z
发表时间:
2021-01-29
期刊:
Genome biology
影响因子:
12.3
作者:
[Pembroke WG, Hartl CL, Geschwind DH]
通讯作者:
Geschwind DH
DOI:
10.7554/elife.85069
发表时间:
2023-11-01
期刊:
eLife
影响因子:
7.7
作者:
[Purandare C, Mehta M]
通讯作者:
Mehta M
Moving bar of light evokes vectorial spatial selectivity in the immobile rat hippocampus.
移动的光条会引起不动的大鼠海马体的矢量空间选择性。
DOI:
10.1038/s41586-022-04404-x
发表时间:
2022
期刊:
Nature
影响因子:
64.8
作者:
[Purandare,ChinmayS, Dhingra,Shonali, Rios,Rodrigo, Vuong,Cliff, To,Thuc, Hachisuka,Ayaka, Choudhary,Krishna, Mehta,MayankR]
通讯作者:
Mehta,MayankR
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
-
批准号:10834336
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2023
-
负责人:DANIEL H GESCHWIND
-
依托单位:
UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC)
-
批准号:10643541
-
项目类别:
-
资助金额:$165.22万
-
财政年份:2023
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
-
批准号:10789246
-
项目类别:
-
资助金额:$2.37万
-
财政年份:2023
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
-
批准号:10295518
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2021
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
-
批准号:10902613
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2021
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Uncovering the genetic mechanisms of the Chromosome 17q21.31 Tau haplotype on neurodegeneration risk in FTD and PSP
-
批准号:10295512
-
项目类别:
-
资助金额:$189.28万
-
财政年份:2021
-
负责人:DANIEL H GESCHWIND
-
依托单位:
High-throughput Modeling of Autism Risk Genes using Zebrafish - DIVERSITY SUPPLEMENT
-
批准号:10818861
-
项目类别:
-
资助金额:$9.4万
-
财政年份:2020
-
负责人:DANIEL H GESCHWIND
-
依托单位:
High-throughput modeling of autism risk genes using zebrafish
-
批准号:10478187
-
项目类别:
-
资助金额:$75.66万
-
财政年份:2020
-
负责人:DANIEL H GESCHWIND
-
依托单位:
High-throughput modeling of autism risk genes using zebrafish
-
批准号:10121604
-
项目类别:
-
资助金额:$81.18万
-
财政年份:2020
-
负责人:DANIEL H GESCHWIND
-
依托单位:
High-throughput modeling of autism risk genes using zebrafish
-
批准号:10264069
-
项目类别:
-
资助金额:$75.68万
-
财政年份:2020
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Genetic Investigation of Minimally Verbal Children with ASD
-
批准号:10470956
-
项目类别:
-
资助金额:$44.83万
-
财政年份:2019
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Genetic Investigation of Minimally Verbal Children with ASD
-
批准号:10001019
-
项目类别:
-
资助金额:$44.85万
-
财政年份:2019
-
负责人:DANIEL H GESCHWIND
-
依托单位:
Genetic Investigation of Minimally Verbal Children with ASD
-
批准号:10689725
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2019
-
负责人:DANIEL H GESCHWIND
-
依托单位:
2/2-Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders
-
批准号:9766386
-
项目类别:
-
资助金额:$53.13万
-
财政年份:2018
-
负责人:DANIEL H GESCHWIND
-
依托单位:
2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders
-
批准号:10438564
-
项目类别:
-
资助金额:$88.15万
-
财政年份:2018
-
负责人:DANIEL H GESCHWIND
-
依托单位:
2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders
-
批准号:10084569
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2018
-
负责人:DANIEL H GESCHWIND
-
依托单位:
2/2 Discovery and validation of neuronal enhancers associated with the development of psychiatric disorders
-
批准号:9924665
-
项目类别:
-
资助金额:$78.48万
-
财政年份:2018
-
负责人:DANIEL H GESCHWIND
-
依托单位:
1/2 Cross modal integration of molecular and physiological networks in ASD
-
批准号:9479597
-
项目类别:
-
资助金额:$114.26万
-
财政年份:2017
-
负责人:DANIEL H GESCHWIND
-
依托单位:
1/2 Cross modal integration of molecular and physiological networks in ASD
-
批准号:9757836
-
项目类别:
-
资助金额:$106.75万
-
财政年份:2017
-
负责人:DANIEL H GESCHWIND
-
依托单位:
2/3 Integrative Genomic Analysis of Human Brain Development and Autism
-
批准号:9330219
-
项目类别:
-
资助金额:$63.75万
-
财政年份:2016
-
负责人:DANIEL H GESCHWIND
-
依托单位:
海外基金